Skip to main content
. Author manuscript; available in PMC: 2010 May 19.
Published in final edited form as: Curr Immunol Rev. 2010 May 1;6(2):137–148. doi: 10.2174/157339510791111718

Figure 3.

Figure 3

Figure 3

Mechanisms by which mesenchymal stem cells may become oncogenic after incorporation of a transgene. (A) Incorporation of an immortalizing transgene may result in the loss of normal cell-cycle checkpoints, karyotypic instability, or other changes which cause uninhibited proliferation of cells. (B) Insertional mutagenesis may disrupt a critical regulatory locus, resulting in dysfunction of the normal mechanisms of tumor suppression.

HHS Vulnerability Disclosure